LIFECORE BIOMEDICAL, INC. \DE\ - COM (LFCR)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
20.7 M
Holdings value Q1 2024
$110 M
Value change Q1 2024
+$1.26 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
72
Number of buys Q1 2024
35
Number of sells Q1 2024
-33
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
514766104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 20.7 M $110 M +$1.26 M $5.31 73
2023 Q4 20.4 M $126 M +$7.78 M $6.19 75
2023 Q3 17.5 M $131 M -$4.24 M $7.55 66
2023 Q2 18 M $174 M -$21.8 M $9.67 75
2023 Q1 21.1 M $79.8 M -$20.9 M $3.78 78
2022 Q4 24.7 M $160 M -$423 K $6.48 89
2022 Q3 22.9 M $204 M -$4.23 M $8.89 80
2022 Q2 24.5 M $244 M -$5.43 M $9.97 83
2022 Q1 23.5 M $272 M -$4.46 M $11.58 93
2021 Q4 25.3 M $280 M +$2.98 M $11.10 93
2021 Q3 25.5 M $235 M +$6.26 M $9.22 91
2021 Q2 25.3 M $284 M -$5.26 M $11.25 90
2021 Q1 25.8 M $274 M -$6.65 M $10.60 90
2020 Q4 26.5 M $287 M -$2.51 M $10.85 92
2020 Q3 25.2 M $245 M +$4.94 M $9.72 92
2020 Q2 23 M $183 M -$667 K $7.96 86
2020 Q1 25.2 M $219 M -$4.61 M $8.69 82
2019 Q4 27.1 M $306 M +$284 K $11.31 91
2019 Q3 26.5 M $287 M -$10.5 M $10.87 99
2019 Q2 27.5 M $257 M +$10 M $9.37 94
2019 Q1 26.3 M $323 M +$1.99 M $12.28 89
2018 Q4 25.9 M $306 M -$192 K $11.84 87
2018 Q3 25.6 M $366 M -$3.19 M $14.40 86
2018 Q2 24.5 M $365 M -$4.22 M $14.90 87
2018 Q1 26.3 M $343 M +$5.88 M $13.05 86
2017 Q4 25.1 M $316 M +$375 K $12.60 86
2017 Q3 25.8 M $334 M +$6.01 M $12.95 91
2017 Q2 25.3 M $376 M +$3.37 M $14.85 93
2017 Q1 25.1 M $301 M +$27 M $12.00 79
2016 Q4 24.6 M $340 M -$4.66 M $13.80 90
2016 Q3 24.9 M $334 M -$7.76 M $13.41 88
2016 Q2 25.5 M $275 M +$12.8 M $10.76 89
2016 Q1 25 M $263 M +$7.1 M $10.50 90
2015 Q4 24.3 M $287 M +$6.28 M $11.83 105
2015 Q3 23.8 M $277 M -$6.5 M $11.67 109
2015 Q2 23.9 M $345 M -$138 K $14.43 106
2015 Q1 24 M $335 M +$730 K $13.95 96
2014 Q4 24 M $332 M -$1.35 M $13.81 103
2014 Q3 24.2 M $294 M +$2.43 M $12.25 102
2014 Q2 23.9 M $298 M +$4.41 M $12.49 98
2014 Q1 23.2 M $259 M -$9.17 M $11.16 94